SUPRIYA LIFESCIENCE LIMITED

SUPRIYA.BO
Exchange BSE, Currency in INR
Loading price...

Overview

Previous Close807.25
Open886.20
Ask0.00
Bid968.70
Day's Range846.85 - 968.70
52 Week Range545.65 - 968.70
PE Ratio(TTM)37.27
Market Cap₹7,796Cr
Volume₹2,39,189
Avg. Volume₹19,027
Face Value₹NaN
Dividend Yield0.12%

Performance

ABSCAGR
YTD1 Month3 Months1 Year2 Years5 Years10 Years
No results to display

Profit/Loss

PARTICULARS
No results to display

Company Profile

Sector: Healthcare
Industry: Biotechnology
HQ Location: Mumbai, India
Website: https://www.supriyalifescience.com
Founder, Executive Chairman & Whole Time Director: Dr. Satish Waman Wagh
Employees: 515
About Company:
Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in antihistamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, the company offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, it is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessation, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic stem cell transplantation, and anti-migraine. Supriya Lifescience Limited was founded in 1987 and is headquartered in Mumbai, India.
DISCLAIMER: Stock prices are not real time and the delay can range from a few seconds to several minutes. The data displayed are solely for informational purposes, not for trading purposes or advice.